Past CureTalks
New Developments in Breast Cancer Screening and Treatment
Breast cancer is the second most common cancer in women (although men can get it too). Some breast cancers are driven by inherited…
Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although…
Understanding the FDA approved New Drug, Selinexor and its Use in Multiple Myeloma
Recently, the FDA approved a new cancer drug called Selinexor. This drug has been found to be successful in treating multiple myeloma in…
The Promise of Prevention. Multiple Myeloma and The Promise Study
Nearly all patients with multiple myeloma first develop one of its precursor conditions. People with these conditions do not have any symptoms, and…
Will Precision Medicine work for me? Advances and Challenges in Cancer Research
Precision medicine is an emerging approach in cancer treatment and prevention. It is a shift away from a one-size-fits-all approach and requires sharing…